dipyridamole has been researched along with Rectal Diseases in 1 studies
Dipyridamole: A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)
dipyridamole : A pyrimidopyrimidine that is 2,2',2'',2'''-(pyrimido[5,4-d]pyrimidine-2,6-diyldinitrilo)tetraethanol substituted by piperidin-1-yl groups at positions 4 and 8 respectively. A vasodilator agent, it inhibits the formation of blood clots.
Rectal Diseases: Pathological developments in the RECTUM region of the large intestine (INTESTINE, LARGE).
Excerpt | Relevance | Reference |
---|---|---|
"Hemorrhoids were found in all patients." | 1.27 | Rectal bleeding induced by Dipyridamole. ( Bayer, I; Creter, D; Kyzer, S; Lewinski, UH, 1986) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bayer, I | 1 |
Kyzer, S | 1 |
Creter, D | 1 |
Lewinski, UH | 1 |
1 other study available for dipyridamole and Rectal Diseases
Article | Year |
---|---|
Rectal bleeding induced by Dipyridamole.
Topics: Dipyridamole; Gastrointestinal Hemorrhage; Hemorrhoids; Humans; Platelet Aggregation; Rectal Disease | 1986 |